Medicus Pharma (MDCX) Net Cash Flow Growth (1y) (2025)

Medicus Pharma (MDCX) Net Cash Flow Growth (1y) (2025) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	NCF Growth (1y) (Qtr)
1	Johnson & Johnson	652.20 Bn	631.44 Bn	17.26 Bn	93.66%
2	AbbVie	469.51 Bn	462.94 Bn	12.70 Bn	-323.06%
3	Merck	376.81 Bn	369.67 Bn	12.21 Bn	248.11%
4	Novartis Ag	303.04 Bn	295.35 Bn	11.24 Bn	195.58%
5	Astrazeneca	257.61 Bn	252.71 Bn	12.86 Bn	-0.70%
6	Amgen	237.37 Bn	223.38 Bn	7.24 Bn	349.49%
7	Gilead Sciences	181.73 Bn	178.55 Bn	6.22 Bn	-55.11%
8	Pfizer	159.66 Bn	147.96 Bn	10.94 Bn	-517.34%
9	Gsk	106.24 Bn	102.07 Bn	8.24 Bn	78.10%
10	Medicus Pharma	14.88 Mn	-298,205.43	-	-

Download Data